Featured stories

High-priority stories from the last three weeks, ranked by interest.

1 items1 sources1 stocks

Current filter: FHTX

Zacks-Oct 28, 01:32 PM

Foghorn Therapeutics Inc. (FHTX) Expected to Beat Earnings Estimates: Should You Buy? - Zacks Investment Research

Foghorn Therapeutics Inc. (FHTX) Expected to Beat Earnings Estimates: Should You Buy? - Zacks Investment Research（摘要待生成）

FHTXearningscorporate_earningspharmaceuticals